Piramal Enterprises share price jumps 8% after $140 million deal with Life Molecular Imaging

  • Stock Market today: Piramal Enterprises share price gained more than 8% in the intraday trades on Tuesday. Piramal Enterprises announced that will be receiving post $140 million deal with Life Molecular Imaging

Ujjval Jauhari
Published14 Jan 2025, 03:13 PM IST
Stock Market Today: Piramal Enterprises share price jumps $140 million deal
Stock Market Today: Piramal Enterprises share price jumps $140 million deal (Pixabay)

Stock Market Today: Piramal Enterprises share price gained more than 8% during the the intraday trades on Tuesday. Piramal Enterprises announced that it will be receiving post $140 million deal with Life Molecular Imaging. Piramal Enterprises had entered agreement to divestment of one of its step-down subsidiaries (Piramal Imaging SA) to Alliance Medical Acquistionco Limited

Pirmal Enterprises share price opened at 960.05 on the BSE on Tuesday, slightly higher than the previous close of 950.35. The Piramal share price there after gained further more to intraday highs of 1027.75, which translated into gains of more than 8%.

Also Read | Penny stock skyrockets 8% as it sets record date for a rights issue

Pirmal Enterprises Deal

Piramal Enterpises in 2018 had agreed to divestment of one of its step-down subsidiaries (Piramal Imaging SA) to Alliance Medical Acquistionco Limited (AMAL). The consideration agreed to be paid for such divestment included deferred consideration which was contingent on future profits of Piramal Imaging SA and its subsidiaries (the “Imaging Group”)

Also Read | Prism Johnson share price dips 6% as exchange sought clarification

Pirmal Enterrprises now In its release on the exchanges on Monday 13 January 2025 said that " We wish to inform you that the Company has now been informed by Life Healthcare Group Holdings Limited (Life Healthcare), (part of the group that acquired Piramal Imaging SA from the Company in 2018), that they have entered into binding agreements for sale of Life Molecular Imaging Limited, a member of the Imaging Group, which agreement is subject inter alia to receipt of the approval of the shareholders of Life Healthcare and various regulatory and other approvals.

Also Read | Stocks to buy under ₹100: Experts recommend three shares to buy today — 14 Jan

On completion of the Proposed Transaction, the Company (through its subsidiary) will become eligible to receive an estimated amount of USD 140 million (subject to final closing adjustments), expected to be received by the Company in FY 2026. The Company may also receive further amounts in subsequent years from any eligible profits and future earnouts relating to the Imaging Group, subject to a maximum of USD 200 million (inclusive of the above USD 140 million)

Disclaimer: The views and recommendations made above are those of individual analysts or broking companies, and not of Mint. We advise investors to check with certified experts before taking any investment decisions.

 

 

 

Catch all the Business News , Market News , Breaking News Events and Latest News Updates on Live Mint. Download The Mint News App to get Daily Market Updates.

Business NewsMarketsStock MarketsPiramal Enterprises share price jumps 8% after $140 million deal with Life Molecular Imaging
MoreLess